Search clinical trials for: anidulafungin

Total 38 results

Radboud University Medical Center

Completed

Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease (ANIDULAPK)

Leukemia | Leukemia, Myeloid, Acute | Myelodysplastic Syndrome

Netherlands
National Cancer Institute (NCI)

Completed

Anidulafungin in Treating Immunocompromised Children With Neutropenia

Unspecified Childhood Solid Tumor, Protocol Specific | Neutropenia | Infection

United States
Pfizer

Completed

Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom

Candidiasis

United Kingdom
Daren K. Heyland
Pfizer; Queen's University; The Physicians' Services Incorporated Foundation

Terminated

Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment (CANTREAT)

Ventilator Associated Pneumonia | Respiratory Tract Infection

Canada
Radboud University Medical Center

Completed

Anidulafungin Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ADOPT) (ADOPT)

Obesity Morbid

Netherlands
Pfizer

Terminated

An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System

Candidiasis | Fungemia | Neutropenia

Poland, Russian Federation, France, Bosnia and Herzegovina, Italy, Slovakia
Pfizer
Vicuron Pharmaceuticals

Completed

The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)

Candidiasis

United States
Pfizer
Vicuron Pharmaceuticals

Completed

The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.

Candidiasis

United States
Pfizer
Vicuron Pharmaceuticals

Completed

A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).

Aspergillosis

United States
Pfizer
Vicuron Pharmaceuticals

Completed

Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17

Neutropenia

United States
Pfizer

Terminated

An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida

Candidiasis | Fungemia

Belgium, United States, Canada, Switzerland, Netherlands, Bulgaria, Portugal, Romania, Russian Federation
Universidade Federal do Rio de Janeiro

Completed

Negative Beta Glucan in ICU Patients

Candidemia

Brazil
Michael Cohen-Wolkowiez

Completed

Anidulafungin PK in Infants and Toddlers

Invasive Fungal Infections

United States
Pfizer

Completed

Anidulafungin In Treatment Of Candidemia In Asian Subjects

Candidemia

Taiwan, India, Thailand, Philippines
Medical University of Vienna

Unknown

Anidulafungin During Continuous Venovenous Hemofiltration (CVVHF)

Acute Renal Failure | Infection

Austria
National Cancer Institute (NCI)

Completed

Anidulafungin Versus Fluconazole in the Treatment of Candidemia

Candidiasis | Candida

United States
Texas Tech University Health Sciences Center
University of Texas Southwestern Medical Center; National Center for Research...

Completed

Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations

Obesity | Mycoses

United States
Elisabethinen Hospital
Pfizer

Terminated

Anidulafungin in Patients With Hematologic Malignancies (ECALTA)

Hematologic Malignancies

Austria
Pfizer

Completed

A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects

Candidemia | Aspergillosis

United States
Pfizer

Terminated

Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)

Aspergillosis

United States
Pfizer

Completed

Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis

Aspergillosis

United States, Australia, Canada, Greece, Belgium, Germany, Korea, Republic of, Poland, Russian Federation, Spain, Turkey, Thailand, Brazil, Czech Republic, France, India, Italy, Netherlands, Peru, Portugal, Singapore, Switzerland, ... and more
Pfizer

Terminated

A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis

Candidemia

China
Pfizer

Completed

Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis

Candidiasis

United States, Korea, Republic of
Duke University
Pfizer

Completed

β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients

Invasive Candidiasis

United States
Fundacion SEIMC-GESIDA
Pfizer

Completed

Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients (AVALTRA)

Fungal Infection | Liver Disease

Spain
Sarder Patel Medical College
Ohio State University

Completed

Efficacy of Radio-frequency Induced Heat (RFH)Therapy in Treatment of Cutaneous Leishmaniasis in India

Cutaneous Leishmaniasis

India
Poznan University of Medical Sciences
University at Buffalo; The Greater Poland Cancer Centre

Active, not recruiting

Translational PKPD Modeling of Anti-infective Drugs Used in Pediatric Units.

Population Modeling of Anti-infective Drugs

Poland
Astellas Pharma Europe B.V.
World Health Information Science Consultants, LLC

Completed

Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents (MYCOS)

Systemic Fungal Infections

United States
Pfizer

Withdrawn

Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects

Aspergillosis | Invasive Pulmonary Aspergillosis | Neuroaspergillosis
Pfizer

Completed

This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis

Candidemia | Invasive Candidiasis

Panama, Brazil, Mexico, Chile, Colombia
Pfizer
Vicuron Pharmaceuticals

Completed

The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis

Candidiasis

United States
Duke University
Pediatric Pharmacology Research Units Network

Completed

Antimicrobial PK in Infants With Suspected or Confirmed Infection

Infection

United States
University of Pittsburgh

Completed

Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients

Mycoses | Fungemia | Central Nervous System Fungal Infections | Lung Diseases, Fungal

United States
U.S. Bioscience

Completed

A Study of Trimetrexate Plus Leucovorin in Children With Pneumocystis Carinii Pneumonia

HIV Infections | Pneumonia, Pneumocystis Carinii

United States
Pfizer

Completed

Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis

Candidemia

United States, Taiwan, Spain, United Kingdom, Korea, Republic of, Brazil, Greece, Canada, Italy, Russian Federation
Erasmus Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development; Stichting...

Recruiting

Azole-echinocandin Combination Therapy for Invasive Aspergillosis (IA-DUET)

Invasive Aspergillosis

Belgium, Netherlands
Pfizer

Completed

Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study (ICE)

Invasive Candidiasis

Czech Republic, Belgium, Austria, Portugal, Russian Federation, Turkey, Canada, Germany, Italy, United Kingdom, Hungary, France, Slovakia, Denmark, Romania, Netherlands, Poland, Greece, Ukraine
Scynexis, Inc.

Suspended

A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole (MARIO)

Candidemia | Candidiasis, Invasive

United States, Korea, Republic of, Greece, Canada, France, Belgium, Germany, Italy, Spain, South Africa, Bulgaria, Israel

Search clinical trials for: anidulafungin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations